ID

22307

Description

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00397228

Link

https://clinicaltrials.gov/show/NCT00397228

Keywords

Versions (1)
  1. 5/29/17 5/29/17 -
Uploaded on

May 29, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Parkinson Disease NCT00397228

English

Eligibility Parkinson Disease NCT00397228

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the participant is 30 years or older at time of pd diagnosis.
Description

Age | Parkinson Disease

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0030567
written informed consent is obtained.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
participants have a clinical diagnosis of idiopathic parkinson's disease of < 7 years.
Description

Parkinson Disease disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0872146
hoehn and yahr stages i-iii.
Description

Hoehn and Yahr Stage

Data type

boolean

Alias
UMLS CUI [1]
C3639483
negative drug screen
Description

Drug screen negative

Data type

boolean

Alias
UMLS CUI [1]
C0919819
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the participant has atypical or drug-induced parkinson's disease.
Description

Atypical Parkinson Disease | Parkinson Disease Drug-induced

Data type

boolean

Alias
UMLS CUI [1]
C1868596
UMLS CUI [2,1]
C0030567
UMLS CUI [2,2]
C0458082
the participant has dementia.
Description

Dementia

Data type

boolean

Alias
UMLS CUI [1]
C0497327
the participant has a clinically significant clinical laboratory value and/or clinically significant unstable medical or psychiatric illness.
Description

Laboratory Results Clinical Significance | Illness Unstable | Mental disorders Unstable

Data type

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C2826293
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C0443343
treatment within the six months prior to screening with bupropion, methylphenidate, reserpine, alpha methyldopa, or amphetamine.
Description

Bupropion | Methylphenidate | Reserpine | Methyldopa | Amphetamines

Data type

boolean

Alias
UMLS CUI [1]
C0085208
UMLS CUI [2]
C0025810
UMLS CUI [3]
C0035179
UMLS CUI [4]
C0025741
UMLS CUI [5]
C0002667
the participant has a history of alcohol, narcotic, or any other drug abuse within the past 2 years.
Description

Substance Use Disorders | Narcotic Abuse

Data type

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0524661
the participant has received an investigational drug within 60 days of screening visit.
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
Back to the top of the page

Similar models

Eligibility Parkinson Disease NCT00397228

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Parkinson Disease
Item
the participant is 30 years or older at time of pd diagnosis.
boolean
C0001779 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
Informed Consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
Parkinson Disease disease length
Item
participants have a clinical diagnosis of idiopathic parkinson's disease of < 7 years.
boolean
C0030567 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hoehn and Yahr Stage
Item
hoehn and yahr stages i-iii.
boolean
C3639483 (UMLS CUI [1])
Drug screen negative
Item
negative drug screen
boolean
C0919819 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Atypical Parkinson Disease | Parkinson Disease Drug-induced
Item
the participant has atypical or drug-induced parkinson's disease.
boolean
C1868596 (UMLS CUI [1])
C0030567 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
Dementia
Item
the participant has dementia.
boolean
C0497327 (UMLS CUI [1])
Laboratory Results Clinical Significance | Illness Unstable | Mental disorders Unstable
Item
the participant has a clinically significant clinical laboratory value and/or clinically significant unstable medical or psychiatric illness.
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0004936 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
Bupropion | Methylphenidate | Reserpine | Methyldopa | Amphetamines
Item
treatment within the six months prior to screening with bupropion, methylphenidate, reserpine, alpha methyldopa, or amphetamine.
boolean
C0085208 (UMLS CUI [1])
C0025810 (UMLS CUI [2])
C0035179 (UMLS CUI [3])
C0025741 (UMLS CUI [4])
C0002667 (UMLS CUI [5])
Substance Use Disorders | Narcotic Abuse
Item
the participant has a history of alcohol, narcotic, or any other drug abuse within the past 2 years.
boolean
C0038586 (UMLS CUI [1])
C0524661 (UMLS CUI [2])
Investigational New Drugs
Item
the participant has received an investigational drug within 60 days of screening visit.
boolean
C0013230 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial